Cardiac dysfunction in liver cirrhosis
A tissue Doppler imaging study from Egypt
Keywords:
Tissue Doppler Imaging, liver cirrhosis, systolic function, diastolic functionAbstract
Background: Patients with liver cirrhosis suffer from various cardiac abnormalities, which may influence their outcome. Tissue Doppler recording of the mitral and tricuspid annular diastolic velocities can be used to assess diastolic function accurately. There has been very little published information regarding RV diastolic function in liver cirrhosis. This study is aimed at evaluating right and left ventricular systolic and diastolic functions in post hepatitis C liver cirrhosis patients using conventional echocardiography and tissue Doppler imaging.
Methods: This study was conducted on 75 adults from inpatient and outpatient services of the Theodor Bilharz Research Institute (TBRI) hospital. They were divided into two groups: Group 1 included 50 patients with post hepatitis C liver cirrhosis; and Group 2 included 25 normal adults serving as a control group. All patients and normal volunteers were subjected to clinical examination, laboratory evaluation, abdominal ultrasonography and echocardiographic studies with tissue Doppler imaging for evaluation of left and right ventricular systolic and diastolic functions.
Results: The mitral flow showed significant increase in A wave velocity, as well as DT and IVRT with a significant decrease in E/A ratio in Group 1 compared to Group 2 (P<0.01). The tricuspid flow also showed a significant increase in A wave velocity (P<0.01) and DT (P<0.05) in addition to a significant decrease in E wave velocity and E/A ratio (P<0.01) in Group 1 as compared to Group 2. At the mitral annulus, we found a significant increase in average Aa velocity, E/Ea ratio and average systolic wave velocity S, in addition to a statistically significant decrease in the average Ea velocity and average Ea/Aa (P<0.01) in Group 1 as compared to Group 2. At the tricuspid annulus, there were significant increases in the average Aa velocity (P<0.01), S velocity (P<0.01) and E/Ea (P<0.05) together with a statistically significant decrease in the average Ea/Aa and average Ea velocity (P<0.01) in Group 1 compared to Group 2.
Conclusion: It is important to evaluate the cardiovascular function in every patient with cirrhosis, especially if the patient is a candidate for any intervention that may affect haemodynamics.
References
Daniel K, Podolsky, Curt J. Isselbacher. Cirrhosis and Alcoholic Liver Dissease. Harrison’s Principles of
Internal Medicine 14 Th Edition 1997; 2: 1704
Sherlock S. Hepatic Cirrhosis. In: Disease of the liver and biliary System, ed 10. Oxford: Blackwell
Scientific Publication, 1993;358-367
Abelmann WH, Kowalski HJ, McNeely WF. The circulation of the blood in alcohol addicts; the cardiac
output at rest and during moderate exercise. Q J Stud Alcohol 1954;15:1-8
Dadhich S, Goswamia A , Jainb VK, Gahlotc A, Kulamarvaa G, Bhargavaa N. Cardiac dysfunction in
cirrhotic portal hypertension with or without ascites. Annals of Gastroenterology 2014; 27, 1-6
Thomas H., Marwick. Myocardial Imaging: Textbook on Tissue Doppler and SpeckleTracking. Blackwell.
ISBN: 978-1- 2007; 4051-6113-8.
Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for
cardiac sonographers. J Am Soc Echocardiogr. 2009 ;22(7):776-792. doi: 10.1016/j.echo.2009.04.027,
PMid: 19560657
Sade LE, Gulmez O, Eroglu S, Sezgin A, Muderrisoglu H. Noninvasive estimation of right ventricular
filling pressure by ratio of early tricuspid inflow to annular diastolic velocity in patients with and without
recent cardiac surgery. J Am Soc Echocardiogr. 2007; 20: 982-988. doi: 10.1016/j.echo.2007.01.012,
PMid: 17555928
Utsunomiya H, Nakatani S, Nishihira M, Kanzaki H, Kyotani S, Nakanishi N, Kihara Y, Kitakaze M.
Value of estimated right ventricular filling pressure in predicting cardiac events in chronic pulmonary
arterial hypertension. J Am Soc Echocardiogr. 2009 ;22(12):1368-1374. doi: 10.1016/j.echo.2009.08.023,
PMid: 19944957
Soyoral Y, Süner A, Kıdır V, Arıtürk Z, Balakan O, Halil Değertekin H,The effects of viral cirrhosis on
cardiac ventricular function Eur J Gen Med 2004; 1(2): 15-18
Vinereanu D, Khokhar A, Fraser AG. Reproducibility of pulsed wave tissue Doppler echocardiography. J
Am Soc Echocardiogr. 1999;12:492–499.
Carolyn Y, Scott D, Solomon. Clinician Update; A Clinician’s Guide to Tissue Doppler Imaging.
Circulation. 2006;113:396-398. doi: 10.1161/CIRCULATIONAHA.105.579268, PMid: 16534017
Gottdiener J.S. Bendnarz I., Devereaux R. et al. American Society of Echocardiography recommendations
for use of echocardiography in clinical trials. Journal of American Society of Echocardiography 2004;
:1086 :1119
Devereaux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy:
Comparison to necropsy findings. American Journal of Cardiology 1986; 57: 450-458.
Wong F, Liu P, Lilly L, et al. Role of cardiac structural and functional abnormalities in the pathogenesis of
hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999; 97:259–267.
De Marco M, Chinali M, Romano C, Benincasa M, D'Addeo G, D'Agostino L, de Simone G. Increased left
ventricular mass in pre-liver transplantation cirrhotic patients. J Cardiovasc Med 2008; 9(2):142-146. doi:
2459/JCM.0b013e3280c7c29c, PMid: 18192806
Bernal V, Pascual I, Lanas A, Esquivias P, Piazuelo E, Garcia-Gil FA, Lacambra I, Simon MA. Cardiac
function and aminoterminal pro-brain natriuretic peptide levels in liver-transplanted cirrhotic patients. Clin
Transplant. 2012; 26: 111–116. doi: 10.1111/j.1399-0012.2011.01438.x, PMid: 21447142
Finucci G, Desideri A, Sacerdoti D, Bolongnesi M, Merkel C et al. Left ventricular diastolic function in
liver cirrhosis. Scand J Gastroenterol. 1996; 31: 279-284.
Eldeeb M, Fouda R, Hammady M, Rashed L. Echocardiographic Evaluation of Cardiac Structural and
Functional Changes in Hepatitis C Positive Non-Alcoholic Liver Cirrhosis Patients and Their Plasma NT- ProBNP Levels. Life Science Journal, 2012;9(1): 786-782.
Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathpphysiological review of circulatory dysfunction
in liver disease. Heart 2002 ; 87:9-15.
Ziada D, Gaber R, NesreenKotb N, Ghazy M, Nagy H. Predictive Value of N-terminal Pro B-type
Natriuretic Peptide in Tissue Doppler-Diagnosed Cirrhotic Cardiomyopathy. Heart Mirror Journal. 2011;
(1):264-270.
Baik S, Fouad T and Lee S. Cirrhotic cardiomyopathy. Orphanet Journal of Rare Diseases. 2007; 2:15 doi:
1186/1750-1172-2-15.
Alexopoulou A, Papatheodoridis G, Pouriki S, Chrysohoou C, Raftopoulos L, Stefanadis C, Pectasides D.
Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transplant Internation
; 25 (11):1174-1181. doi: 10.1111/j.1432-2277.2012.01547.x, PMid: 22909305
Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic
function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll
Cardiol.1988; 12: 426–440.
Møller S, Henriksen JH. Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic
cardiomyopathy. Scand J Gastroenterol. 2001; 36: 785-794.
Haykal M, Negm H. Cardiovasular effects of HCV in Egyptian population. CVD Prevention and Control J
; 4 (suppl.1)
Saleh A, Akira Matsumori A, Negm H, Fouad H, Onsy A, Shalaby M, Hamdy E. Assessment of cardiac
involvement of hepatitis C virus; tissue Doppler imaging and NTproBNP study Journal of the Saudi Heart
Association 2011; (23): 217–223. doi: 10.1016/j.jsha.2011.04.005, PMid: 23960652 PMCid: PMC3727462
Pozzi M, Carugo S, Boari G, Pecci V, Ceglia S, Maggiolini S, et al. Functional and structural cardiac
abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26:1131–1137.
Rivas-Gotz C, Manolios M, Thohan V, Nagueh SF. Impact of left ventricular ejection fraction on
estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J
Cardiol 2003;91:780–4. doi: 10.1016/S0002-9149(02)03433-1
Ginés P ،Arroyo V،Rodés J،Robert W. Schrier RW. Ascites and Renal Dysfunction in Liver Disease:
Pathogenesis, Diagnosis, and treatment. 2nd edition Blackwell publishing. 2005:148-149
Pouriki S, Alexopoulou A, Chrysochoou C, Raftopoulo L, Papatheodoridis G, Christodoulos Stefanadis C,
Dimitrios Pectasides D. Left ventricle enlargement and increased systolic velocity in the mitral valve are
indirect markers of the hepatopulmonary syndrome. Liver International 2011; 31(9): 1388–1394. doi:
1111/j.1478-3231.2011.02591.x, PMid: 21771264
Karabulut A, Iltumur K, Yalcin K et al. Hepatopulmonary syndrome and right ventricular diastolic
functions: an echocardiographic examination. Echocardiography 2006;23(4): 271–278. doi:
1111/j.1540-8175.2006.00210.x, PMid: 16640703
Wahl A, Praz F, Schwerzmann M, Bonel H, Koestner SC, Hullin R, et al. Assessment of right ventricular
systolic function: comparison between cardiac magnetic resonance derived ejection fraction and pulsed- wave tissue Doppler imaging of the tricuspid annulus. Int J Cardiol 2011;151: 58-62. doi:
1016/j.ijcard.2010.04.089, PMid: 20537415
Meluzin J, Spinarova L, Bakala J, Toman J, Krejci J, Hude P, et al. Pulsed Doppler tissue imaging of the
velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right
ventricular systolic function. Eur Heart J 2001;22:340-8. doi: 10.1053/euhj.2000.2296, PMid: 11161953
Rushmer RF, Crystal DK, Wagner C. The functional anatomy of ventricular contraction. Circ Res
;1:162-70.
HowardLS Grapsa J, Dawson D, Bellamy, Chambers JB, Masani ND et al. Echocardiographic assessment
of pulmonary hypertension: standard operating procedure. Eur Respir Rev 2012; 21: 125, 239–248. doi:
1183/09059180.00003912, PMid: 22941889.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
